Ophthalmologists Urged to Be Alert for Signs of Child Abuse
Case study in the Journal of AAPOS highlights need for vigilance
Philadelphia, PA, April 25, 2012 – It has been estimated that roughly 4% to 6% of child abuse victims present first to an ophthalmologist. In a case study in the April issue of the Journal of American Association of Pediatric Ophthalmology and Strabismus, doctors at the University of Washington and the Seattle Children’s Hospital describe a case of a 13-month-old girl who was initially diagnosed with corneal abrasion and a mild infection. She was eventually identified as a victim of child abuse.
“In retrospect, there were clinical and laboratory findings that might have raised concerns about child abuse earlier in the course of the condition,” says senior author Avery H. Weiss, MD, Roger Johnson Clinical Vision Laboratory, Division of Ophthalmology, Seattle Children’s Hospital. “This troubling case is a reminder to be vigilant for the possibility of child abuse in chronic or recurrent keratoconjunctivitis with dermatitis of an uncertain etiology.”
The child presented with left lower eyelid swelling, sensitivity to light, and increased tearing. Her vision was reduced compared with normal for children her age. She was treated with topical and oral antibiotics, but her condition progressively worsened over the course of two weeks. During a three-day stay in the hospital, her condition improved and she was discharged. Despite continued therapy, the irritation and inflammation persisted. She was then brought to a local trauma hospital with a brain hemorrhage and bruising consistent with child abuse. The patient’s antibacterial eye drops were confiscated, and found to have been laced with household bleach. Criminal charges are pending.
Dr. Weiss notes that looking back, several features of the examination were more consistent with a locally applied irritant than with infection, including the isolated lower eyelid swelling, the inferior corneal abrasion, and inflammation confined to the lower conjunctiva.
Journal of AAPOS Editor-in-Chief David G. Hunter, MD, PhD, of the Children’s Hospital Boston and Harvard Medical School, comments, “This tragic story of an unexpected manifestation of mental illness serves as a reminder to physicians in all specialties to remain vigilant for child abuse whenever a patient fails to improve despite what appears to be appropriate therapy.”
# # #
Notes for editors
“Chronic Keratoconjunctivitis with Dermatitis as a Presenting Sign of Child Abuse,” by Daniel B. Moore, MD, Erin P. Herlihy, MD, and Avery H. Weiss, MD, DOI: 10.1016/j.jaapos.2011.11.006. It appears in the Journal of AAPOS, Volume 16, Issue 2 (April 2012) published by Elsevier.
Full text of the article is available at to credentialed journalists upon request; contact Rachael Zaleski at +1 215 239 3658, email@example.com to obtain a copy or request an interview with the authors.
About the Journal of AAPOS ( http://www.journals.elsevierhealth.com/periodicals/ympa)
Journal of AAPOS presents expert information on children's eye diseases and on strabismus as it impacts all age groups. Major articles by leading experts in the field cover clinical and investigative studies, treatments, case reports, surgical techniques, descriptions of instrumentation, current concept reviews and new diagnostic techniques. The Journal is the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
About the American Association for Pediatric Ophthalmology and Strabismus ( www.aapos.org)
The goals of the AAPOS, the American Association for Pediatric Ophthalmology and Strabismus are to advance the quality of children's eye care, support the training of pediatric ophthalmologists, support research activities in pediatric ophthalmology and advance the care of adults with strabismus.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
+1 215 239 3658